Glaxo to reveal HIV hope

Further evidence of the growing success of scientists fighting Aids is likely to be announced by Glaxo Wellcome, the drugs company, at an international Aids conference in Washington today.

However, the findings are being treated with caution by some researchers, who fear the rise in cocktail treatments - combinations of two or more drugs to treat HIV, the virus that causes Aids - brings pitfalls.

Glaxo Wellcome, in conjunction with its partner Vertex, a US biotechnology company listed on the Nasdaq stock exchange, will announce results for a combination treatment of two protease inhibitor compounds developed by Vertex.

The paper will describe the effect of using 1592U89 and 141W494 on a a small group of Aids patients. Seven were tested, and it is understood that while two withdrew from the trial because of side-effects the other five had virus levels reduced to undetectable.

The news follows hard on an announcement on Friday for a combination of Glaxo's 3TC and Bristol-Myers Squibb's d4T, which could also reduce HIV in some patients' blood to undetectable levels. But if the patient had previously used a combination of Glaxo's 3TC and its AZT, the new treatment caused a drop of only 50 per cent - not enough, it is believed, to make much difference to the patient's health.

So-called cocktail therapies have proved to be highly promising ways of treating patients. But the conference has also noted that their proliferation will make them more difficult to track, with each new combination needing more and more analysis to show which is the most effective at different stages of the disease.

If a doctor prescribes the wrong drugs, or gives them to a patient in the wrong order, he risks leaving the patient defenceless farther down the road.

"Each choice minimises your future," said Harvard researcher Dr Cal Cohen. "If a doctor guesses wrong, then you're done with plan B and plan A, and have fewer choices for plan C."

Robert Frost, director of the American Foundation for Aids Research, warned of "the growing concern that the order in which we use combinations of drugs will affect therapeutic options in the future".

Because of the ability of HIV to mutate, many Aids patients are now resistant to older treatments, such as Glaxo's AZT.

The sombre note will temper the optimism of the Glaxo findings, which analysts are unconvinced signal any significant impact yet on the company's profitability. Glaxo, though, is desperate to find replacements as fast as it can for its billion-dollar ulcer drug Zantac, sales of which have been hit badly by coming off patent in the US.

Suggested Topics
Start your day with The Independent, sign up for daily news emails
New Articles
tvDownton Abbey Christmas special
Arts and Entertainment
Wolf (Nathan McMullen), Ian (Dan Starky), The Doctor (Peter Capaldi), Clara (Jenna Coleman), Santa Claus (Nick Frost) in the Doctor Who Christmas Special (BBC/Photographer: David Venni)
tvOur review of the Doctor Who Christmas Special
News
peopleIt seems you can't silence Katie Hopkins, even on Christmas Day...
News
news
PROMOTED VIDEO
News
i100
Arts and Entertainment
Left to right: Stanley Tucci, Sophie Grabol and Christopher Eccleston in ‘Fortitude’
tvSo Sky Atlantic arrived in Iceland to film their new and supposedly snow-bound series 'Fortitude'...
Arts and Entertainment
Jenna Coleman as Clara Oswald in the Doctor Who Christmas special
tvForget the rumours that Clara Oswald would be quitting the Tardis
Arts and Entertainment
Japanese artist Megumi Igarashi showing a small mascot shaped like a vagina
art
News
The Queen delivers her Christmas message
newsTwitter reacts to Her Majesty's Christmas Message
Arts and Entertainment
tv
Life and Style
fashion
ebooks
ebooksA year of political gossip, levity and intrigue from the sharpest pen in Westminster
Latest stories from i100
Have you tried new the Independent Digital Edition apps?
Independent Dating
and  

By clicking 'Search' you
are agreeing to our
Terms of Use.

iJobs Job Widget
iJobs Money & Business

Selby Jennings: Oil Operations

Highly Competitive: Selby Jennings: Our client, a leading European Oil trading...

The Jenrick Group: Night Shift Operations Manager

£43500 per annum + pension + holidays: The Jenrick Group: Night Shift Operatio...

SThree: Trainee Recruitment Consultant - LONDON

£20000 - £25000 per annum + OTE £40,000 + Car + Pension: SThree: SThree are a ...

SThree: Trainee Recruitment Consultant

£20000 - £25000 per annum + OTE £35K: SThree: We consistently strive to be the...

Day In a Page

A Christmas without hope: Fears grow in Gaza that the conflict with Israel will soon reignite

Christmas without hope

Gaza fears grow that conflict with Israel will soon reignite
After 150 years, you can finally visit the grisliest museum in the country

The 'Black Museum'

After 150 years, you can finally visit Britain's grisliest museum
No ho-ho-hos with Nick Frost's badass Santa

No ho-ho-hos with Nick Frost's badass Santa

Doctor Who Christmas Special TV review
Chilly Christmas: Swimmers take festive dip for charity

Chilly Christmas

Swimmers dive into freezing British waters for charity
Veterans' hostel 'overwhelmed by kindness' for festive dinner

Homeless Veterans appeal

In 2010, Sgt Gary Jamieson stepped on an IED in Afghanistan and lost his legs and an arm. He reveals what, and who, helped him to make a remarkable recovery
Isis in Iraq: Yazidi girls killing themselves to escape rape and imprisonment by militants

'Jilan killed herself in the bathroom. She cut her wrists and hanged herself'

Yazidi girls killing themselves to escape rape and imprisonment
Ed Balls interview: 'If I think about the deficit when I'm playing the piano, it all goes wrong'

Ed Balls interview

'If I think about the deficit when I'm playing the piano, it all goes wrong'
He's behind you, dude!

US stars in UK panto

From David Hasselhoff to Jerry Hall
Grace Dent's Christmas Quiz: What are you – a festive curmudgeon or top of the tree?

Grace Dent's Christmas Quiz

What are you – a festive curmudgeon or top of the tree?
Nasa planning to build cloud cities in airships above Venus

Nasa planning to build cloud cities in airships above Venus

Planet’s surface is inhospitable to humans but 30 miles above it is almost perfect
Surrounded by high-rise flats is a little house filled with Lebanon’s history - clocks, rifles, frogmen’s uniforms and colonial helmets

Clocks, rifles, swords, frogmen’s uniforms

Surrounded by high-rise flats is a little house filled with Lebanon’s history
Return to Gaza: Four months on, the wounds left by Israel's bombardment have not yet healed

Four months after the bombardment, Gaza’s wounds are yet to heal

Kim Sengupta is reunited with a man whose plight mirrors the suffering of the Palestinian people
Gastric surgery: Is it really the answer to the UK's obesity epidemic?

Is gastric surgery really the answer to the UK's obesity epidemic?

Critics argue that it’s crazy to operate on healthy people just to stop them eating
Homeless Veterans appeal: Christmas charity auction Part 2 - now LIVE

Homeless Veterans appeal: Christmas charity auction

Bid on original art, or trips of a lifetime to Africa or the 'Corrie' set, and help Homeless Veterans
Pantomime rings the changes to welcome autistic theatre-goers

Autism-friendly theatre

Pantomime leads the pack in quest to welcome all